These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

937 related articles for article (PubMed ID: 30215149)

  • 1. Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
    Sircana A; Framarin L; Leone N; Berrutti M; Castellino F; Parente R; De Michieli F; Paschetta E; Musso G
    Curr Diab Rep; 2018 Sep; 18(10):98. PubMed ID: 30215149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
    Zhu T; Goodarzi MO
    Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
    Huda MN; Kim M; Bennett BJ
    Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome and type 2 diabetes: where we are and where to go?
    Sharma S; Tripathi P
    J Nutr Biochem; 2019 Jan; 63():101-108. PubMed ID: 30366260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut-Microbial Metabolites, Probiotics and Their Roles in Type 2 Diabetes.
    Zhai L; Wu J; Lam YY; Kwan HY; Bian ZX; Wong HLX
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota and Metabolic Disorders: Advances in Therapeutic Interventions.
    Akash MSH; Fiayyaz F; Rehman K; Sabir S; Rasool MH
    Crit Rev Immunol; 2019; 39(4):223-237. PubMed ID: 32421966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the microbiome in the management of children with type 2 diabetes mellitus.
    Brar PC; Kohn B
    Curr Opin Pediatr; 2019 Aug; 31(4):524-530. PubMed ID: 31299021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes.
    Caesar R
    Can J Diabetes; 2019 Apr; 43(3):224-231. PubMed ID: 30929665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
    Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
    Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
    Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
    Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
    Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiota and Complications of Type-2 Diabetes.
    Iatcu CO; Steen A; Covasa M
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the Significance of Gut Microbiota in Diabetes Pathogenesis and Management-A Narrative Review.
    Młynarska E; Wasiak J; Gajewska A; Steć G; Jasińska J; Rysz J; Franczyk B
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.